retatrutide fat loss clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Understanding whether fatigue is a direct peptide effect or a caloric deficit symptom changes the management approach entirely

It has been reported that there is no reduction in its secretion in patients with T2DM [13] but a nearly total loss of insulinotropic effect is observed, even at supraphysiological concentrations, implying the existence of GIP resistance [14]

doi: 10.1038/ijo.2012.208

Unlike men who may see testosterone suppression, women often experience disrupted menstrual cycles due to the caloric deficit and rapid body composition changes

PYY (Peptide YY) : PYY is a satiety hormone produced by L cells in the intestines, which, similar to GLP-1, increases in concentration after meals and can reduce food intake, thereby potentially aiding in combating obesity